Formally, the estimated risk differences for the <50 copies/ml cut-off indicated in both the intention to treat and per protocol analysis a higher risk difference for failure in patients with PI/r monotherapy that was of borderline significance whereas the corresponding relative summary estimates were not all statistically significant.
← all excerpts
Effectiveness of protease inhibitor monotherapy versus combination antiretroviral maintenance therapy: a meta-analysis.
1
—
—